Journal of the American College of CardiologyAged80 and overFemaleHumansMale
Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
Clara Bonanad-Lozano, Sergio García Blas, Ignacio Amat-Santos, Rafael Gonzalez-Manzanares, Juan Sanchís, Diego López Otero, Luis Nombela Franco, Livia Gheorge, Jorge Sanz-Sánchez, Carlos Baladrón Zorita, Andrés Iñiguez Romo, Antonio Jesús Muñoz García, Victoria Vilalta, Soledad Ojeda, Gabriela Veiga Fernández
Published: 202510.1016/j.jacc.2025.07.051
Abstract
BACKGROUND: Patients with aortic stenosis who undergo transcatheter aortic valve implantation (TAVI) experience a great improvement in health status. Dapagliflozin has been shown to reduce death and heart failure (HF) in these patients. However, the…
Preview only. Read the full abstract at the source